Transactions under Novozymes’ stock buyback program

As of November 13, Novozymes has purchased an accumulated 7,032,696 shares with a transaction value of DKK 1,811.3 million under the stock buyback program Novozymes announced in Company announcement No. 17, 2014 and initiated February 17, 2014.

Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2014.
The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:       
 
Number
 of shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement
6,882,696
 
1,769,950,361
November 7, 2014
30,000
274.27
8,228,057
November 10, 2014
30,000
273.80
8,213,953
November 11, 2014
30,000
277.04
8,311,177
November 12, 2014
30,000
 276.14
8,284,171
November 13, 2014
30,000
275.50
8,264,966
Total accumulated under the program
7,032,696
 
1,811,252,685
In addition, transactions necessitated by Novozymes’ previously established incentive programs have resulted in a net sale by Novozymes of 5,106 B shares in the period from November 7 to November 13, 2014. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.
 
Following the transactions stated above, Novozymes owns a total of 10,892,954 treasury shares, corresponding to 3.4% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.
 
Contact information
Investor Relations:
 
 
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Press and media:
 
 
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+44 7976138265
Paige Donnelly (USA)
+1 919 218 4501
Meng Lian (China)
+86 136 9923 1164
Henrique Pellini (Brazil)
+55 41 9288 0282